Transplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation ConditioningTransplantation, AutologousHematologic NeoplasmsGraft SurvivalTransplantation, IsogeneicTransplantation ChimeraIsoantigensHistocompatibilityLymphocyte Culture Test, MixedGraft vs Tumor EffectLeukemiaTissue DonorsT-LymphocytesRecurrenceTreatment OutcomeHematopoietic Stem Cell MobilizationCombined Modality TherapyGranulocyte Colony-Stimulating FactorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRemission InductionWhole-Body IrradiationGraft vs Leukemia EffectCyclophosphamideStem Cell TransplantationMelphalanAnemia, AplasticSkin TransplantationImmunosuppressionHistocompatibility TestingLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteAntigens, CD34Graft vs Host ReactionAntineoplastic Combined Chemotherapy ProtocolsLymphocyte ActivationSurvival AnalysisRetrospective StudiesBusulfanLeukapheresisGraft RejectionTransplantation ImmunologyBlood Component RemovalCytotoxicity, ImmunologicMice, Inbred BALB CNeoplasm, ResidualMice, Inbred C57BLTime FactorsLymphocyte DepletionSiblingsMultiple MyelomaImmunosuppressive AgentsSpleenMyeloablative AgonistsSurvival RateCarmustineSalvage TherapyEtoposideRadiation ChimeraLeukocyte TransfusionDendritic CellsCytarabineOpportunistic InfectionsVidarabineMatched-Pair AnalysisBlood Transfusion, AutologousImmune TolerancePrecursor Cell Lymphoblastic Leukemia-LymphomaInfectionHematopoiesisHLA AntigensLymphocytesHodgkin DiseaseAcute DiseaseActuarial AnalysisHematopoietic Stem CellsChimerismT-Lymphocytes, CytotoxicTransplantation ToleranceHistocompatibility AntigensMyelodysplastic SyndromesMice, Inbred StrainsCytomegalovirus InfectionsVincristineMice, Inbred C3HFeasibility StudiesH-2 AntigensCytotoxicity Tests, ImmunologicBlood TransfusionFatal OutcomeCD4-Positive T-LymphocytesImmunotherapy, AdoptiveKiller Cells, NaturalAllograftsImmune SystemFollow-Up Studies